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COMMENTARY
Patients do not need Congressman
Langevin’s clone-to-kill bill
BY FATHER NICANOR AUSTRIACO, O.P.
4/15/10 12:00 am
Last year, on March 9, 2009, President Obama signed Executive Order 13505 that liberalized
the Federal government’s funding of human embryonic stem cells. It allowed scientists to
obtain funding from the National Institutes of Health in Washington, DC, to experiment with
new stem cell lines derived from the destruction of so-called “leftover” human embryos.
The executive order was and remains, not only immoral and unjust, but also scientifically
unnecessary.
This year, on March 9, 2010, Congressman James R. Langevin of Rhode Island, along with
nine other U.S. representatives, introduced the Stem Cell Research Advancement Act (H.R.
4808) in the House of Representatives to amend the Public Health Service Act to provide for
human destructive embryo research. If signed into law, the bill would not only codify President
Obama’s Executive Order 13505, but would also permit scientists to clone human embryos as
long as the embryo is destroyed and not allowed to survive! Representative Langevin’s
proposed legislation, H.R. 4808, is a clone-to-kill bill.
The proposed legislation permits cloning-to-kill by redefining the scientific definition of human
cloning. According to Langevin’s bill, “[t]he term ‘human cloning’ means the implantation of the
product of transferring the nuclear material of a human somatic cell into an egg cell from
which the nuclear material has been removed or rendered inert into a uterus or the functional
equivalent of a uterus.’’ In contrast, the scientific consensus defines cloning as the creation
and not the implantation of a cloned embryo. By manipulating the definition of cloning,
Representative Langevin and his congressional colleagues want to reward scientists who
would derive stem cells from the cloning and killing of human embryos, by giving them federal
monies to fund their research with these embryonic stem cell lines. This bill would lead to the
creation and the destruction of innocent human beings, and thus, like the President’s
executive order, is immoral and unjust.
Significantly, patients do not need Langevin’s clone-to-kill bill. In the past year, scientists have
continued to perfect the nuclear reprogramming technology that will allow doctors to obtain
patient-specific stem cells from adult human cells without the need for either human eggs or
human embryos. These reprogrammed patient-specific stem cells, called induced pluripotent
stem (iPS) cells, are comparable to embryonic stem (ES) cells. They are also cheaper and
easier to make than the stem cells derived from destructive human embryo research. In fact,
they are so cheap and so easy to work with, that our undergraduate biology majors here at
Providence College could readily learn how to work with iPS cells! Moreover, though several
studies had suggested that iPS cells may be subtlety different from and therefore less efficient
than ES cells, the Hochedlinger Laboratory at the Harvard Stem Cell Institute has recently
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reported that they have identified the key genetic difference between these two kinds of stem
cells. Their discovery suggests that scientists will be able to significantly improve the quality of
iPS cells by further manipulating their genes.
In time, physicians will be able to use iPS cells to generate replacement cells for patients
suffering from a variety of chronic diseases including Type I Juvenile Diabetes, Lou Gehrig’s
Disease, and Parkinson’s Disease. One seminal proof-of-principle study has already shown
that iPS cells can be used to cure sickle cell anemia in a humanized mouse model. Several
months ago, for the first time, a research team from Spain created iPS cells that could be
used to cure patients with a rare genetic disorder called Fanconi Anemia. In time, iPS cells
may also be able to help patients with spinal cord injury to recover lost functioning. Finally, iPS
cells are already being used for disease modeling and drug discovery. All of this, I want to
stress, is already happening now, and will happen without Congressman’s Langevin’s clone-
to-kill bill.
In sum, there is much promise and excitement in nuclear reprogramming (iPS) technology.
Thus, it is not surprising that Ian Wilmut, creator of Dolly the cloned sheep, has rejected
cloning and has focused his current research efforts, not on cloned embryonic stem cells, but
on iPS cells. Again, for the same reason, it is not surprising that the California Institute for
Regenerative Medicine (CIRM) – a state agency expressly created to encourage embryonic
stem cell research – last year gave 10 of its 14 major research grants, not to fund ES cell
work, but to advance adult stem cell and iPS work instead. Professor Wilmut and CIRM affirm
what Congressman Langevin and his colleagues deny, that adult stem cells and iPS cells, and
not cloned embryonic stem cells, are the hope of the future.
Congressman Langevin is a self-identified pro-life Democrat who is a member of the Bi-
Partisan Congressional Pro-Life Caucus. By abandoning his support for this unjust, immoral,
and unnecessary clone-to-kill bill, he can prove that he is not only pro-life but also pro-patient
as well.
Fr. Nicanor Austriaco, O.P., is an assistant professor of biology and an instructor of theology
at Providence College. He also serves as a staff ethicist at the Dominican Friars Health Care
Ministry of New York and as an advisor to Rhode Island Right to Life.
